SBIR/STTR Research Award

Developing Human-Compatible Needleless Delivery Systems for Administering Bioscavengers

Award identifier 904dd4201e4854f12e758227a357a285a576e0ebc225329e11ec003f56f2fac4Awarding agency Department of Defense · Army

Award amount

$688,615

Program and phase

SBIR · Phase II

Award year

2003

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Defense
Branch
Army
Recipient company
FELTON INTERNATIONAL, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

Phase II will focus on the design and development of a prototype needle-free injection system for administering BChE enzyme into humans to provide protection against chemical warfare agents. The Phase I proof-of-concept demonstrated the accelerateddelivery of BChE into the circulatory system using needle-free injection. The second phase of this project will consist of the following three tasks: 1) Develop and quantify a prototype needle-free injector. This task includes product, environmentaland human safety testing. A protector cap will be used to prevent pathogen transfer between patients; 2) Conduct trials on non-human primates to determine the percent of enzyme delivered, the peak level of enzyme activity and the duration of the enzymeat that level; 3) Determine the efficacy of this enzyme as a bioscavenger by exposing injected rodents to OP or pesticides; and 4) Deliver a prototype injector to the Army for chemical warfare studies. The overall goal of this project is to provide theArmy with a system to allow rapid injection of the enzyme into soldiers in the event of a chemical attach on the battlefield. In order to achieve this goal, the usability, safety and efficacy of the device will be proven. For the military, this devicewould allow rapid injection of troops prior to a potential chemical exposure. In this situation, troops should be injected 12 hours prior to possible exposure and re-injected weekly as long as the threat continues. Needle-free injection has been shown tobe faster, less painful, safer and more efficacious. In general, needle-free administration of vaccines, biologicals and antibiotics dramatically increase the speed of injection, improves drug absorption, reduces costs and eliminates the hazardsassociated with sharps and sharps disposal. Needle-free administration of drugs has wide application throughout the military and public health sectors.--------------------------------------- Needle & Syringe----------------- Needle-freeDelivery Speed ----------------- 120 injections / hour----------- 600 injections / hourCost per Injection-------------- .20 for disposable syringe----- $.08 for needle-freeDose Accuracy------------------- +-17% ------------------------- +-2%Disposal Method ---------------- Sharps Incineration ----------- Bio-hazard bag (No sharps)Volume (10,000 injections)------ 37.2 Cubic feet -------------- 6.4 Cubic feet Source: WHO Bulletin; 2002,80(11)

Technology keywords

Not reported

Agency intelligence

Department of Defense

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.